Chiome Bioscience Inc. (JP:4583) has released an update.
Don't Miss our Black Friday Offers:
- Unlock your investing potential with TipRanks Premium - Now At 40% OFF!
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Chiome Bioscience Inc. reported a decrease in net sales and net income for the six-month period ending June 30, 2024, with net sales at 263 million yen, a 26.5% drop from the previous year, and net income showing a loss of 563 million yen. The company’s equity ratio improved slightly to 68.0% from 65.1% at the end of the previous fiscal year. Chiome has not announced any dividends for the fiscal year ending in December 2024 and maintains its forecast for Drug Discovery Support Business sales at 720 million yen without providing a full financial forecast due to the difficulty of estimating results in Drug Discovery and Development Business.
For further insights into JP:4583 stock, check out TipRanks’ Stock Analysis page.